ISPE Releases Baseline Guide, Risk-MaPP


Jun 03, 2010

ISPE, a global not-for-profit association of 24,000 pharmaceutical science and manufacturing professionals, announces the release of the Baseline Guide Risk-based Manufacture of Pharmaceutical Products (Risk-MaPP) to be available third quarter 2010.
Risk-MaPP provides a scientific risk-based approach, based on ICH Q9, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance between product quality and operator safety.
A Live Webinar entitled "Risk-MaPP: What Is It and Why You Need It" will be held on Sept. 14 as an introduction for professionals not yet familiar with, or who seek a better understanding of, the importance of Risk-MaPP. The webinar is a prerequisite to upcoming conference sessions, and should be attended by conference delegates for maximum understanding. A recorded version of the webinar will also be available in late September.
Upcoming conference events featuring Risk-MaPP include:
• ISPE Brussels Conference: Sept. 20-23; Brussels, Belgium
• ISPE Risk-MaPP Conference: Oct. 4-5  Washington D.C.
•  Japan Conference: Oct. 21-22; Tokyo, Japan
• Singapore Conference, Oct. 25-26; Singapore
• ISPE 2010 Annual Meeting: Nov. 7-10, Orlando
For more information,  visit:
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments